Sorted by Revenue (Highest to Lowest). Click any column header to re-sort.
| S.No. |
Company Profile ↕ |
Revenue ▼ |
Operating Profit ↕ |
ROCE / ROE ↕ |
Cash ROCE / ROE ↕ |
Updated ↕ |
Action |
| 1. |
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA | BSE: 524715)
|
₹58,462.04 Cr |
₹14,793.55 Cr |
17.17 % |
14.81 % |
Nov 04, 2026 |
View Data
|
| 2. |
Cipla Limited (NSE: CIPLA | BSE: 500087)
|
₹28,162.59 Cr |
₹4,671.92 Cr |
13.17 % |
11.10 % |
Nov 16, 2026 |
View Data
|
| 3. |
Biocon Limited (NSE: BIOCON | BSE: 532523)
|
₹16,927.00 Cr |
₹1,841.10 Cr |
3.71 % |
4.02 % |
Nov 16, 2026 |
View Data
|
| 4. |
Ajanta Pharma Limited (NSE: AJANTPHARM | BSE: 532331)
|
₹5,452.86 Cr |
₹1,221.69 Cr |
25.78 % |
11.17 % |
Nov 20, 2026 |
View Data
|
| 5. |
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS | BSE: 544222)
|
₹4,359.02 Cr |
₹367.48 Cr |
8.44 % |
27.14 % |
Nov 20, 2026 |
View Data
|
| 6. |
Venus Remedies Limited (NSE: VENUSREM | BSE: 526953)
|
₹769.60 Cr |
₹134.19 Cr |
19.39 % |
22.51 % |
Nov 11, 2026 |
View Data
|
| 7. |
Aarey Drugs & Pharmaceuticals Limited (NSE: AAREYDRUGS | BSE: 524412)
|
₹472.27 Cr |
₹10.42 Cr |
6.85 % |
6.66 % |
Nov 20, 2026 |
View Data
|
| 8. |
NATCO Pharma Limited: In-Depth Corporate Profile
|
₹437.59 Cr |
₹152.75 Cr |
— |
— |
Nov 16, 2026 |
View Data
|
| 9. |
Beta Drugs Limited (NSE)
|
₹384.83 Cr |
₹58.55 Cr |
15.10 % |
9.62 % |
Nov 20, 2026 |
View Data
|
| 10. |
Themis Medicare Limited (NSE: THEMISMED | BSE: 530199)
|
₹342.24 Cr |
₹3.26 Cr |
0.76 % |
-0.76 % |
Nov 18, 2026 |
View Data
|
| 11. |
Albert David Limited (NSE: ALBERTDAVD | BSE: 524013)
|
₹333.60 Cr |
₹3.16 Cr |
0.78 % |
-1.90 % |
Nov 20, 2026 |
View Data
|
| 12. |
Bal Pharma Limited (NSE: BALPHARMA | BSE: 524824)
|
₹311.66 Cr |
₹20.82 Cr |
16.48 % |
24.42 % |
Nov 20, 2026 |
View Data
|
| 13. |
Vivimed Labs Limited (NSE: VIVIMEDLAB | BSE: 532660)
|
₹116.27 Cr |
-₹28.90 Cr |
-5.64 % |
-0.34 % |
Nov 11, 2026 |
View Data
|
| 14. |
Vaishali Pharma Limited (NSE: VAISHALI)
|
₹112.61 Cr |
— |
— |
— |
Nov 18, 2026 |
View Data
|
| 15. |
Biofil Chemicals and Pharmaceuticals Limited (NSE: BIOFILCHEM | BSE: 524396)
|
₹28.40 Cr |
₹0.38 Cr |
1.71 % |
-2.71 % |
Nov 20, 2026 |
View Data
|